COSM
Cosmos Health Inc. (COSM) SWOT Analysis Analysis (2026)
No material changes this month.
Strengths
COSM’s only modest strength is a current ratio just above 1.0, which is weaker than larger peers that typically maintain more robust liquidity buffers.
Net debt to EBITDA is negative, indicating EBITDA is not covering debt in a conventional sense and leaving the balance sheet less resilient than profitable peers.
The company’s cash conversion cycle of 54.6 days is manageable but not a structural advantage versus peers with faster working-capital turns and stronger cash generation.
Return on invested capital is deeply negative at -46.4%, showing capital deployment is destroying value relative to peers that earn positive returns on invested capital.
Weaknesses
Return on invested capital of -46.4% is the dominant weakness, because it signals persistent value destruction versus peers that generate positive economic returns.
The quick ratio of 0.92 suggests near-term liquidity is tighter than peers with stronger liquid asset coverage, increasing dependence on operating cash flow.
Debt to equity of 0.77 is not extreme, but it is burdensome for a business with negative returns, leaving less flexibility than better-capitalized competitors.
The 54.6-day cash conversion cycle ties up working capital longer than efficient peers, which constrains reinvestment and amplifies funding pressure.
Opportunities
If COSM improves working-capital discipline, the 54.6-day cash conversion cycle could narrow the gap with peers and release cash for operations.
A return to positive invested-capital returns would materially improve peer positioning, because even modest profitability would reverse the current value-destruction profile.
Stronger liquidity management could lift the quick ratio above 1.0, aligning COSM more closely with peers that have better short-term financial flexibility.
Any operating leverage from scale would matter disproportionately here, because peers with healthier margins already convert revenue into returns more efficiently.
Threats
Persistent negative ROIC threatens long-term competitiveness, because peers with positive returns can reinvest more aggressively while COSM destroys capital.
Tighter liquidity than peers raises refinancing and execution risk, especially if operating cash flow remains insufficient to fund working-capital needs.
A prolonged cash conversion cycle leaves COSM more exposed than faster-turning peers to demand shocks, supplier pressure, and inventory or receivable slippage.
Higher leverage relative to weak earnings capacity can quickly become restrictive, whereas stronger peers can absorb volatility without impairing strategic flexibility.
Overall Score
COSM’s structural positioning versus peers is weak because deeply negative capital returns and tight liquidity outweigh any limited balance-sheet or working-capital stability.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Cosmos Health Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
